I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer
This study is to evaluate the efficacy of tucidinostat combined with exemestane as neoadjuvant strategy in estrogen receptor-positive early breast cancer patients and explore the genetic model which can predict neoadjuvant endocrine therapeutic results.
estrogen
invasive breast cancer
tucidinostat
cancer
exemestane
- 2 views
- 05 Aug, 2020